MedTrace Logo

Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients

NCT00381368 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-12-04

No results posted yet for this study

Summary

The purpose of the study is to determine the efficacy and safety of a three time repeated loading dose of intravenous ibandronate (ibandronic acid), 6 mg, in breast cancer patients with painful skeletal metastases.

Conditions

Interventions

DRUG

Ibandronic acid

Sponsors & Collaborators

Principal Investigators

  • Outi Paija, MD, PhD · Dept of Oncology, Turku University Hospital, Finland

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00381368 on ClinicalTrials.gov